# Progress Note 07 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Paul Robeson (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML048-SYN
- Date: 2026-10-05
- Fictional facility: St. Posthumous Health Center
- Fictional author: Theodore Bankole-Ashworth, MD
- Calendar frame: modern shifted

- Visit type: Preventive Visit
- Services: CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning) on the same day

## Chief complaint

Periodic adult preventive visit. **S**

## History of present illness

Mr. Robeson is a 59-year-old singer and actor with recurrent major depression who comes for the preventive visit booked in the spring. Six weeks ago aripiprazole was added to venlafaxine 225 mg; he has taken 5 mg each morning for four weeks. He sleeps about six and a half hours, his energy and interest have come back, and he practices every morning and sang at two community gatherings last month. He has noticed no restlessness, stiffness or tremor; his weight is up 1.4 kg in six weeks. The cough from the summer cleared within three weeks. He continues weekly behavioral activation and is planning a small recital. He has had no thoughts of suicide. **S**

| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 59 |
| Depression | PHQ-9 6 on venlafaxine and aripiprazole |
| Side effects | No restlessness or movement problems; weight up 1.4 kg |
| Safety | No thoughts of suicide; safety plan in place |

## Health risk assessment

Completed by the patient on paper in the waiting room and reviewed with him by Dr. Bankole-Ashworth. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good and improving |
| Psychosocial | Persecution and loss of income remain his main stresses; he feels stronger in facing them; supported by friends and his therapist |
| Substance use | AUDIT-C 1 at intake, unchanged; no drug use |
| Tobacco | Never smoked |
| Physical activity | Walks 40 minutes most mornings; swimming twice a week again |
| Nutrition | Regular meals; more vegetables and less fried food since the lipid results |
| Sleep | About six and a half hours; no snoring reported; STOP-BANG 2 |
| Safety | No firearm at home; seat belt always; medicines kept in a locked box |
| Sexual health | One partner; no concerns |
| Activities of daily living | Independent |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever; weight up 1.4 kg in six weeks |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Negative | Voice clear; no hearing loss |
| Cardiovascular | Negative | No chest pain or palpitations |
| Respiratory | Negative | Cough gone |
| Gastrointestinal | Negative | No change in bowel habit or bleeding |
| Genitourinary | Negative | No difficulty passing urine; no nighttime frequency |
| Musculoskeletal | Negative | No joint pain |
| Neurological | Negative | No tremor, stiffness or restlessness |
| Integumentary | Negative | No rash |
| Psychiatric | Positive | Mild low mood on some days; no thoughts of suicide; PHQ-9 6 |

11 systems reviewed. **S**

## Current medications

- Venlafaxine extended-release 75 mg capsules, three capsules (225 mg) each morning with food **S**
- Aripiprazole 5 mg tablet, one tablet each morning **S**

## Allergies

- No known allergy **S**

## Objective

BP 130/80 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 102.4 kg; BMI 28.4 kg/m². All vital signs are synthetic.

PHQ-9: 6. All results are synthetic.

## Change since baseline

- PHQ-9: 22 at baseline, 6 at this visit **S**

## Immunizations given today

- Influenza vaccine, inactivated, trivalent, preservative-free **S**
- Pneumococcal conjugate vaccine, 20-valent (PCV20) **S**
- Zoster vaccine, recombinant, dose 1 of 2 **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Well; weight 102.4 kg, BMI 28.4; blood pressure 130/80 |
| Neck | No lymph nodes; thyroid normal |
| Cardiovascular | Regular rhythm; no murmur |
| Respiratory | Clear |
| Abdomen | Soft; no mass |
| Neurological | No tremor, rigidity or abnormal movements; abnormal involuntary movement examination normal; no akathisia |
| Psychiatric | Warm and engaged; affect fuller; speech at a normal pace |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Periodic adult preventive visit completed**. Health risk assessment reviewed and the prevention plan updated. Influenza, PCV20 and the first recombinant zoster dose given. **S**
   - FIT kit to return within two weeks.
   - Prostate surgery records requested before any PSA decision.
   - Hepatitis B and C screening drawn today.
   - Second zoster dose in two to six months.
   - Next preventive visit in one year.
2. **Recurrent major depression, responding to augmentation** (F33.2). PHQ-9 6 from 22: a response, not yet remission. No akathisia or abnormal movements; weight up 1.4 kg (1.4 percent) at six weeks, below the 5 percent that would call for action. Safety reviewed: no thoughts of suicide; medicines locked; the 988 Suicide & Crisis Lifeline in his phone. ECT remains available if he relapses, as discussed in the summer. **S**
   - Continue venlafaxine 225 mg and aripiprazole 5 mg.
   - Weight at eight and twelve weeks of aripiprazole; A1c and lipids at twelve weeks.
   - Continue behavioral activation; continue treatment for at least a year after remission because the depression is recurrent.
3. **Political persecution and loss of income** (Z60.5). Still a major stressor; he is meeting the social worker monthly about costs. **S**
   - Continue social work support.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 130/80 mmHg; watched on venlafaxine |
| Depression screening and follow-up | Completed today | PHQ-9 6 under treatment; item 9 scored 0 |
| Unhealthy alcohol use screening | Up to date | AUDIT-C 1 at intake; no change |
| Tobacco use | Completed today | Never smoked |
| Colorectal cancer screening | Ordered | No earlier screening; he chose a yearly FIT over colonoscopy; kit given today |
| Prostate cancer screening | Due | Shared decision due: he had prostate surgery about two years ago whose reason is not in this chart; records requested before discussing PSA testing |
| Lipid screening and statin assessment | Completed today | Total cholesterol 204, HDL 46, LDL 132 mg/dL six weeks ago; pooled cohort ten-year risk about 9 percent; statin offered after discussion; he chose diet and activity first, to revisit in a year |
| Diabetes screening | Up to date | A1c 5.6% six weeks ago; repeat at twelve weeks of aripiprazole |
| Lung cancer screening | Not indicated | Never smoked |
| HIV screening | Up to date | Negative at intake |
| Hepatitis C screening | Ordered | Once for adults; drawn today |
| Hepatitis B screening | Ordered | Once for all adults; drawn today; vaccination to follow if not immune |
| Influenza vaccine | Completed today | Seasonal dose |
| Pneumococcal vaccine | Completed today | PCV20, recommended from age 50 |
| Zoster vaccine | Completed today | Recombinant vaccine dose 1 of 2 |
| Tetanus, diphtheria, and pertussis | Up to date | Tdap six years ago on his card |
| COVID-19 vaccine | Due | Discussed; he will decide at the next visit |
| Hepatitis B vaccine | Due | After the screening result, if not immune |

## Advance care planning

Voluntary advance care planning discussion of about 20 minutes, with his consent. He wants full treatment of any illness. He named a health care agent, recorded in the confidential part of the chart and not named here. He asked that any future decision about ECT be his own, made with his own informed consent while he has capacity; this was recorded as his stated preference. To be revisited yearly. **S**

## Guideline basis

- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), U.S. Department of Veterans Affairs and Department of Defense
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Colorectal Cancer: Screening (2021), U.S. Preventive Services Task Force
- Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication (2022), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Mood review with weight in two weeks, at eight weeks of aripiprazole; twelve-week metabolic tests. FIT result and screening results by phone. Second zoster dose in two to six months. Call or text 988 at any time in a crisis. **S**

